- Home
- SYRE vs MTAL Comparison
SYRE vs MTAL Comparison
Compare SYRE & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- MTAL
- Stock Information
- Founded
- SYRE 2013
- MTAL 2021
- Country
- SYRE United States
- MTAL Jersey
- Employees
- SYRE N/A
- MTAL N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- MTAL Blank Checks
- Sector
- SYRE Health Care
- MTAL Finance
- Exchange
- SYRE Nasdaq
- MTAL Nasdaq
- Market Cap
- SYRE 1.1B
- MTAL 1.0B
- IPO Year
- SYRE 2016
- MTAL 2021
- Fundamental
- Price
- SYRE $14.82
- MTAL $12.21
- Analyst Decision
- SYRE Strong Buy
- MTAL Hold
- Analyst Count
- SYRE 5
- MTAL 4
- Target Price
- SYRE $61.25
- MTAL $12.08
- AVG Volume (30 Days)
- SYRE 485.5K
- MTAL 1.2M
- Earning Date
- SYRE 11-06-2025
- MTAL 11-09-2025
- Dividend Yield
- SYRE N/A
- MTAL N/A
- EPS Growth
- SYRE N/A
- MTAL N/A
- EPS
- SYRE N/A
- MTAL N/A
- Revenue
- SYRE N/A
- MTAL $321,804,000.00
- Revenue This Year
- SYRE N/A
- MTAL $17.39
- Revenue Next Year
- SYRE N/A
- MTAL $24.69
- P/E Ratio
- SYRE N/A
- MTAL N/A
- Revenue Growth
- SYRE N/A
- MTAL N/A
- 52 Week Low
- SYRE $10.91
- MTAL $7.69
- 52 Week High
- SYRE $40.26
- MTAL $14.31
- Technical
- Relative Strength Index (RSI)
- SYRE 34.55
- MTAL 64.56
- Support Level
- SYRE $15.80
- MTAL $12.12
- Resistance Level
- SYRE $17.58
- MTAL $12.22
- Average True Range (ATR)
- SYRE 0.74
- MTAL 0.03
- MACD
- SYRE -0.24
- MTAL 0.00
- Stochastic Oscillator
- SYRE 5.32
- MTAL 89.47
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.